(Q41690938)

7 October 2017

1 reference

title

Calcium channel blockers: association with myocardial infarction, mortality, and cancer (English)

1 reference

7 October 2017

Cheng JW

1

1 reference

7 October 2017

Behar L

series ordinal

2

1 reference

7 October 2017

publication date

1 November 1997

1 reference

7 October 2017

published in

Clinical Therapeutics

1 reference

7 October 2017

volume

19

1 reference

7 October 2017

issue

6

1 reference

7 October 2017

page(s)

1255-68; discussion 1253-4

1 reference

The pharmacology of calcium antagonists: a review.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Trends in pharmacologic management of hypertension in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Long‐Term Survival and Use of Antihypertensive Medications in Older Persons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

A delayed answer to the calcium blocker question

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium Antagonists: Antagonists or Protagonists of Mortality in Elderly Hypertensives?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Do calcium channel blockers increase the risk of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium-channel blockade and incidence of cancer in aged populations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium-channel blockers and risk of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Nifedipine and mortality. Grave defects in the dossier

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium antagonists should continue to be used for first-line treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Surgical bleeding: unexpected effect of a calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium channel blockers and cancer: due to loss of immune surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium-channel blockers and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Apoptosis in the pathogenesis and treatment of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Nicotine inhibition of apoptosis suggests a role in tumor promotion.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Effects of calcium channel blockers on in vivo cellular immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

FDA committee recommends stronger warnings against inappropriate use of immediate-release nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980003-3

7 January 2021

10.1016/S0149-2918(97)80003-3

Identifiers

DOI

1 reference

7 October 2017

1 reference